Curta Investigators Awarded 2022 Value in Health Paper of the Year by ISPOR

Resources > News and Events

The International Society of Pharmacoeconomics and Outcomes Research (ISPOR) annually recognizes excellence and achievements in HEOR. The article, “Are Drugs Priced in Accordance with Value? A Comparison of Value-Based and Net Prices Using Institute for Clinical and Economic Review Reports” co-authored by Lisa Bloudek, Curta Partner and CEO, Sean D. Sullivan, Curta Partner and President, and Victor Nguyen, along with University of Washington Affiliate faculty Jens Grueger, received the 2022 Value in Health Paper of the Year Award for outstanding research paper. The paper investigated how Institute of Clinical and Economic Review (ICER) estimated value-based prices (VBP) from 95 comparative- and cost-effectiveness reviews compare to actual net prices.

For the full list of award honorees, visit
https://www.ispor.org/heor-resources/news/view/2022/09/13/ispor-announces-honorees-for-the-2022-health-economics-and-outcomes-research-awards.

To access the publication, visit https://www.sciencedirect.com/science/article/pii/S1098301521001066.